Dr. Forsyth has a strong interest in malignant, invasive glioma brain tumors. He is currently investigating several tumor-inhibiting agents in Phase I and 2 clinical trials. His laboratory interests are in gliomas and melanoma brain metastases. He works using oncolytic viruses as immunotherapies, neurotrophins, and their receptors in melanoma and other brain metastasis.